$599

Dexcom to Build EU Manufacturing Plant; FDA Finds Manufacturing Lapses at Lilly Plant

Two cardiometabolic-related news items have been observed: Dexcom announced its first manufacturing facility in the EU for CGM sensors (view press release); and FDA has reportedly uncovered new manufacturing problems at a Lilly plant (view article). Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here